Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment
dc.contributor.author | Queiroz-Telles, Flavio | |
dc.contributor.author | Nucci, Marcio | |
dc.contributor.author | Colombo, Arnaldo Lopes [UNIFESP] | |
dc.contributor.author | Tobon, Angela | |
dc.contributor.author | Restrepo, Angela | |
dc.contributor.institution | Univ Fed Parana | |
dc.contributor.institution | Universidade Federal do Rio de Janeiro (UFRJ) | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Corp Invest Biol | |
dc.date.accessioned | 2016-01-24T14:06:20Z | |
dc.date.available | 2016-01-24T14:06:20Z | |
dc.date.issued | 2011-04-01 | |
dc.description.abstract | Implantation or subcutaneous mycoses are a frequent health problem in Latin American countries and other tropical and subtropical areas. Although such infections rarely cause disseminated or invasive disease, they have an important impact on public health, and timely diagnosis and appropriate treatment remain important. Although some implantation mycoses are found in immunocompromised persons, the immunocompetent population is the principal target in Latin America. Most etiologic agents are found in soil, vegetation, and decaying matter in tropical, subtropical, and humid environments and infection is commonly the result of penetrating injury. Infections primarily occur (1) among low socioeconomic groups, (2) among those living in rural areas or involved in farming, hunting, or other outdoor activities, and (3) particularly among adult men. This review focuses on the epidemiology of the most clinically significant implantation mycoses in Latin America, i.e., sporotrichosis, eumycetoma, chromoblastomycosis, subcutaneous phaeohyphomycosis, subcutaneous zygomycosis, and lacaziosis. Main epidemiologic findings, clinical manifestations, diagnosis, and treatment options are also discussed. | en |
dc.description.affiliation | Univ Fed Parana, Hosp Clin, Infect Dis Unit, Div Infect Dis,Dept Publ Hlth, BR-8006090 Curitiba, Parana, Brazil | |
dc.description.affiliation | Univ Fed Rio de Janeiro, Univ Hosp, Rio de Janeiro, Brazil | |
dc.description.affiliation | Escola Paulista Med, Dept Med, Div Infect Dis, BR-04023 São Paulo, Brazil | |
dc.description.affiliation | Corp Invest Biol, Medellin, Colombia | |
dc.description.affiliationUnifesp | Escola Paulista Med, Dept Med, Div Infect Dis, BR-04023 São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Schering-Plough | |
dc.description.sponsorship | Merck Co., Inc. | |
dc.description.sponsorship | Astellas | |
dc.description.sponsorship | Janssen | |
dc.description.sponsorship | Merck | |
dc.description.sponsorship | Pfizer | |
dc.description.sponsorship | United Medical | |
dc.format.extent | 225-236 | |
dc.identifier | http://dx.doi.org/10.3109/13693786.2010.539631 | |
dc.identifier.citation | Medical Mycology. London: Informa Healthcare, v. 49, n. 3, p. 225-236, 2011. | |
dc.identifier.doi | 10.3109/13693786.2010.539631 | |
dc.identifier.issn | 1369-3786 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/33582 | |
dc.identifier.wos | WOS:000288323400001 | |
dc.language.iso | eng | |
dc.publisher | Informa Healthcare | |
dc.relation.ispartof | Medical Mycology | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights.license | http://informahealthcare.com/userimages/ContentEditor/1255620309227/Copyright_And_Permissions.pdf | |
dc.subject | subcutaneous mycoses | en |
dc.subject | endemic mycoses | en |
dc.subject | posaconazole | en |
dc.subject | itraconazole | en |
dc.title | Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment | en |
dc.type | info:eu-repo/semantics/article |